Skip to Main Content

Harriet Kluger, MD

Medical Oncology, Hematology & Oncology, Melanoma and Onco-Dermatology, Genitourinary Oncology
Telehealth is available
Learn more about telehealth
Patient type treated
Child, Adult
Accepting new patients
Referral required
From patients or physicians


Dr. Kluger is a medical oncologist who sees patients with melanoma and renal cell carcinoma. Her research interests focus on developing new drug regimens and biomarkers predictive of response to therapies in melanoma and renal cell carcinoma. She participates in a number of clinical trials studying new agents for the treatment of these diseases, both targeting the immune system and the cancer cell. She runs an active research laboratory that studies tumor and immune cells from patients treated with novel therapies to determine mechanisms of resistance to therapy and mediators of toxicity from immune checkpoint inhibitors. The laboratory also conducts pre-clinical studies to improve treatment regimens for patients with melanoma, renal cell carcinoma or brain metastasis.


  • Professor of Medicine (Medical Oncology)
  • Director, Yale SPORE in Skin Cancer, Yale Cancer Center
  • Director, Yale Immuno-Oncology Training Program
  • Associate Cancer Center Director, Education, Training and Faculty Development
  • Deputy Section Chief, Medical Oncology

Education & Training

  • Fellow
    Yale University School of Medicine (2002)
  • Resident
    University of New Mexico (1995)
  • MD
    Tel Aviv University (1993)

Additional Information

  • Yale Cancer Center - Melanoma Program
    Smilow Cancer Hospital at Yale New Haven
    35 Park Street, Ste North Pavilion 8
    New Haven, CT, 06511